08:30 - 12:00 |
 |
The DDL Incubator New for DDL2026 As an added value benefit to those attending DDL 2026 in person, we are delivering a session dedicated to exploring the funding options available to start-ups, biotech founders and similar stakeholders. This session is free to attend but you must register separately. |
|
10:00 |
 |
DDL2026 Registration 10:00 – Poster Hall opens for refreshments 11:00 – Exhibition Hall opens for refreshments |
|
12:00 - 13:30 |
 |
Networking Lunch in the Exhibition Hall and Poster Hall Network with delegates and view the industry exhibition and poster exhibition. Lunch is served in the exhibition hall and the poster hall. |
|
12:00 - 13:00 |
 |
The DDL New Researcher Networking Lunch Paired Networking Session – for new and early career scientists and PhD students only. Lowther Meeting Room, Level -1 Further information coming soon |
|
13:30 |
 |
Conference Opens Welcome by |
|
13:45 |
 |
The DDL Lecture is a prestigious accolade bestowed on individuals who have contributed much to the field of respiratory science. Development challenges with inhaled formulations |
|
14:15 - 15:10 |
SESSION 1 – ADVANCES IN SOLID-STATE FORMULATION |
||
14:20 |
 |
Structure of biologics solid formulations from NMR |
|
14:45 |
 |
Analysing the architecture of engineered particles through nanoscale X-ray Computed Tomography |
|
15:10 - 16:30 |
 |
Refreshment Break Explore the exhibition stands and network with delegates Manned Poster Session – JUDGING The poster exhibition is on Level -2. Poster presenters will be interviewed by the DDL Judges to be considered for the Best Academic and Best Industry Poster. Please allow judges to take priority in talking to the authors during this session. Another manned poster session is scheduled during the Thursday morning refreshment break |
|
16:30: - 17:40 |
SESSION 2 -INHALED ANTIMICROBIALS |
||
16:35 |
 |
Using AI to monitor global trends in emerging infections and applying the data to drug-discovery and prevention strategies |
|
17:00 |
 |
A quantitative systems pharmacology/PKPD perspective on when inhaled administration offers advantages over systemic administration |
|
17:25 |
 |
Spray-dried inhalable powders of an Aspergillus fumigatus sphingosine-1-phosphate lyase inhibitor for cystic fibrosis airways |
|
17:40 - 20:00 |
 |
Welcome Drinks Reception Networking across the conference centre, with drinks and canapes in the exhibition hall and the poster hall. |
|
17:40 - 18:30 |
|
The New Researcher Network – ‘Career Cocktail’ Evening For new and early career researchers and PhD Students only. Lowther Meeting Room, Level -1 With invited guests. Further information coming soon |
08:00 - 09:00 |
|
Registration and Refreshments Explore the exhibition stands and the poster exhibition and network with delegates |
|
09:00 |
Winner of The DDL2026 Emerging Scientist Award Announced The winner of this award will be announced live on stage and will present their research. This award recognises significant scientific accomplishment or innovation during the early stages of an individual’s career in inhalation science. |
||
09:05 |
 |
The DDL2026 Emerging Scientist Winner’s Presentation |
|
09:35 - 12:20 |
SESSION 3 – DIGITAL DRUG DELIVERY (dDDL) |
||
09:40 |
Title to be confirmed Amin Rostami, University of Manchester |
||
10:05 |
 |
Exploratory plasma and CSF exposure modelling of intranasal ondansetron and the implications for nose-to-brain delivery |
|
10:20 - 11:40 |
|
Refreshment Break Explore the exhibition stands and network with delegates Manned Poster Session The poster exhibition is on Level -2. Authors will be at their posters to discuss them with the attendees. |
|
11:40 - 12:20 |
SESSION 3: DIGITAL DRUG DELIVERY (dDDL) – CONTINUED |
||
11:40 |
 |
Towards In-Silico Clinical Trials: Assessing Bioequivalence of Dry Powder Inhalers Based on Regional Lung Deposition |
|
11:55 |
From Design to Delivery: How Digital Innovation Is Reshaping and Accelerating Respiratory Trials Eoin Cassels, Evinova |
||
12:20 - 14:00 |
|
Networking Lunch in the Exhibition Hall and Poster Hall Network with delegates, visit the exhibition stands and view the conference posters. Lunch is served in the exhibition hall and poster hall. |
|
14:00 - 15:20 |
SESSION 4: THE PAT BURNELL YOUNG INVESTIGATOR AWARD Finalists present their work and are judged by the DDL Organising Committee The winner of the competition will be announced following the day’s lectures in the Pentland Auditorium. This award recognises the vision of Pat Burnell and has been designed to encourage junior researchers from either academia or industry to present their work at the DDL Conference. |
||
14:05 |
 |
Droplet Clustering in HFA-152a Metered Dose Inhalers |
|
14:20 |
 |
Platform for assessing physiologically relevant macrophage responses to inhalable formulations: Exposure of dry powder aerosols to macrophages co-cultured with alveolar epithelia Mykaella Mestre, Hovione Farmaciencia S.A. and Institute for Bioengineering and Biosciences |
|
14:35 |
 |
From Broad Activation to Precision Strike: A Pulmonary-Delivered Hybrid OMV-mRNA Platform for Lung Cancer Immunotherapy |
|
14:50 |
 |
Development of a liposomal Cannabidiol formulation for enhanced bioavailability: A comparative evaluation of oral, intranasal, and pulmonary delivery |
|
15:05 |
 |
MLGold: A CFD-Informed Machine Learning Framework for Patient-Specific Inverse Design of Targeted Aerosol Delivery |
|
15:20 - 16:20 |
|
Refreshment Break Explore the exhibition stands and the poster exhibition and network with delegates |
|
16:20 - 17:15 |
SESSION 5 – PROPELLANTS, PLANET & PATIENTS: CLINICAL NEEDS AND ADVOCACY |
||
16:25 |
Formulation challenges, how they were addressed, and regulatory pathways and interactions with regulators. |
||
16:50 |
Innovations in valve mechanics arising from synchrotron X-ray measurements. |
||
17:15 |
|
Awards Ceremony Join us in the Pentland Auditorium as we announce the winners of:
|
|
17:45 |
|
Networking Drinks Reception Networking across the conference centre, with drinks and canapes in the exhibition hall and the poster hall. |
08:30 - 09:30 |
|
Morning Refreshments Explore the exhibition stands and the poster exhibition and network with delegates before the lecture programme begins for the final day |
|
09:30 - 12:30 |
SESSION 6 – SITE-SPECIFIC AEROSOL DELIVERY |
||
09:35 |
 |
Akkermansia Muciniphila: A Mucin-Degrading Next-Generation Probiotic for Pulmonary Drug Delivery |
|
09:50 |
 |
Feasibility of delivering mRNA-LNP via acoustic nebulisation: in vitro and in vivo assessment |
|
10:05 |
Lipid nanoparticle platform iNanoMACRO for inhaled nanoparticles targeting macrophages |
||
10:30 - 11:40 |
|
Refreshment Break Explore the exhibition stands, view the conference posters and network with delegates |
|
11:40 |
SESSION 6 : SITE-SPECIFIC AEROSOL DELIVERY – CONTINUED |
||
11:40 |
 |
The use of impaction parameter-based metrics derived from impactor datasets to support better products, more consistent clinical outcomes, and improved treatment option |
|
12:05 |
 |
Towards standardised compendial testing of nasal products: multi-laboratory evaluation of the Kiel Nasal Inlet for assessment of the fraction below 10 µm |
|
12:20 |
|
Closing remarks |